Higher levels of OPG, sRANKL, IFN-γ, IL-17, and IL-23 (pro-inflammatory) and lower levels of IL-4 (anti-inflammatory) were observed in the GCF of patients with DM, compared to control subjects. This evidence concerns the gene TNFRSF11B and diabetes mellitus.